4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-028074
INTERIM CEO gave up 2,721 shares (to pay taxes)
- INTERIM CEO acquired 9,466 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM CEO | 2024-12-01 | Option exercise | +9,466 | 1,385,854 | D | ||
| Walker Neal INTERIM CEO | 2024-12-01 | Shares withheld for taxes | −2,721 | $4.07 | $11,074 | 1,383,133 | D |
| Derivatives | |||||||
| Walker Neal INTERIM CEO | 2024-12-01 | Option exercise · Restricted Stock Units | −9,466 | 47,334 | D | ||
Loading xslF345X05/form4-12032024_041203.xml…